GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Yantai Dongcheng Biochemicals Co Ltd (SZSE:002675) » Definitions » YoY EPS Growth

Yantai Dongcheng Biochemicals Co (SZSE:002675) YoY EPS Growth : -61.54% (As of Mar. 2025)


View and export this data going back to 2012. Start your Free Trial

What is Yantai Dongcheng Biochemicals Co YoY EPS Growth?

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months. Yantai Dongcheng Biochemicals Co's YoY EPS Growth for the quarter that ended in Mar. 2025 was -61.54%.

Yantai Dongcheng Biochemicals Co's Earnings per Share (Diluted) for the three months ended in Mar. 2025 was ¥0.03.

Yantai Dongcheng Biochemicals Co YoY EPS Growth Historical Data

The historical data trend for Yantai Dongcheng Biochemicals Co's YoY EPS Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Yantai Dongcheng Biochemicals Co YoY EPS Growth Chart

Yantai Dongcheng Biochemicals Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
YoY EPS Growth
Get a 7-Day Free Trial Premium Member Only Premium Member Only 169.95 -63.72 101.06 -33.16 -12.20

Yantai Dongcheng Biochemicals Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
YoY EPS Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 27.87 -64.42 -45.53 122.83 -61.54

Yantai Dongcheng Biochemicals Co YoY EPS Growth Calculation

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months.

Yantai Dongcheng Biochemicals Co's YoY EPS Growth for the fiscal year that ended in Dec. 2024 is calculated as:

YoY EPS Growth (A: Dec. 2024 )
=(Earnings per Share (Diluted) (A: Dec. 2024 )-Earnings per Share (Diluted) (A: Dec. 2023 ))/ | Earnings per Share (Diluted) (A: Dec. 2023 ) |
=(0.223-0.254)/ | 0.254 |
=-12.20 %

Yantai Dongcheng Biochemicals Co's YoY EPS Growth for the quarter that ended in Mar. 2025 is calculated as:

YoY EPS Growth (Q: Mar. 2025 )
=(Earnings per Share (Diluted) (Q: Mar. 2025 )-Earnings per Share (Diluted) (Q: Mar. 2024 )) / | Earnings per Share (Diluted) (Q: Mar. 2024 )) |
=(0.03-0.078)/ | 0.078 |
=-61.54 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Yantai Dongcheng Biochemicals Co YoY EPS Growth Related Terms

Thank you for viewing the detailed overview of Yantai Dongcheng Biochemicals Co's YoY EPS Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Yantai Dongcheng Biochemicals Co Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Yantai Dongcheng Biochemicals Co Ltd (SZSE:002675) » Definitions » YoY EPS Growth
Comparable Companies
SHSE:600993 SHSE:600422 SZSE:300199 SHSE:600129 SZSE:300119 SZSE:002317 SHSE:600211 SHSE:600572 SZSE:002020 SZSE:300026 ZTS XTER:MRK LSE:HLN NSE:SUNPHARMA TSE:4502 XSWX:GALD XSWX:SDZ NSE:DIVISLAB HKSE:03692 XTAE:TEVA
Traded in Other Exchanges
N/A
Address
No. 7 ChangBaishan Road, Yan Tai Development Zone, ShanDong, CHN, 264006
Website
http://www.dcb-group.com
Yantai Dongcheng Biochemicals Co Ltd is a biochemical analytical profile index (API) manufacturers in China. In addition, the company also focuses on the development of finished preparation which covers the therapeutic area of cardiovascular, oncology, orthopedics, and anti-infection. Its product offering includes heparin sodium, chondroitin sulfate, marine collagen, hyaluronic acid, glucosamine, heparinoids, and cytochrome C. The company's API products have been exported to more than fifty countries and regions, including the United States of America, Germany, Austria, and Japan.
Executives
Xin Hong Bo Directors, executives
Luo Zhi Gang Executives
You Shou Yi Directors, executives
Lv Chun Xiang Supervisors
Sun Hong Tao Supervisors
Yi Qiong Executives
Yang Zhen Qiu Executives
Bai Xing Hua Directors, executives
Song Zhao Long Supervisors
Wen Lei Director
Zhu Chun Ping Executives
Qi Dong Qi Directors, executives
Liu Xiao Jie Securities Affairs Representative
Wang En Zheng Independent director
Shi Tao Supervisors

Yantai Dongcheng Biochemicals Co Headlines

No Headlines